Henry Schein (HSIC) Osake Kurssi
Henry Schein Kurssi
Viimeisten 19 vuoden aikana Henry Scheinn liikevaihto kasvoi 5,1 % vuodessa ja ylsi 13,18 Mrd. USD:een. Osakekohtainen tulos on kasvanut 6,5 % vuodessa viimeisten 19 vuoden aikana. Henry Scheinn nettomarginaali 3,0 % on laskenut verrattuna 5,0 %:iin muutama vuosi sitten. Henry Scheinn 12 kuukauden konsensustavoitehinta on 94,50 USD, noin yli kurssia 10,4 %. 25 analyytikosta 15 suosittaa ostoa — kokonaiskonsensus on Osta.
Henry Schein osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Henry Schein liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Henry Schein -osakkeesta
The business model of Henry Schein Inc revolves around being a leading provider of healthcare products and services. With a focus on the dental, veterinary, and medical industries, Henry Schein offers a wide range of products, equipment, and technology solutions to healthcare professionals worldwide. The company's business model emphasizes delivering value, quality, and innovation to its customers. Through strategic partnerships, efficient distribution channels, and a strong customer-centric approach, Henry Schein Inc aims to support healthcare providers in delivering optimal patient care while driving growth and profitability for the company.
Henry Schein Inc is primarily active in the healthcare industry.
The main competitors of Henry Schein Inc in the market include Patterson Companies Inc and Benco Dental Supply Company.
Henry Schein Inc is a leading healthcare solutions provider, catering to both healthcare professionals and manufacturers. Founded in 1932 by Henry Schein and his wife Esther, the company began as a small storefront distributing dental supplies. Over the years, it has grown into a global corporation, offering a wide range of products and services in the dental, animal health, and medical sectors. Henry Schein Inc is committed to enhancing patient care through innovative solutions, advanced technology, and comprehensive support. With a rich history spanning nearly a century, Henry Schein Inc has established itself as a trusted name in the healthcare industry, serving customers in over 190 countries.
Henry Schein Inc, a renowned company in the healthcare industry, has achieved significant milestones throughout its history. Being one of the largest distributors of healthcare products and services, Henry Schein has established itself as a global leader. Some notable achievements include expanding its reach to over 90 countries worldwide, consistently ranking on the Fortune 500 list, and generating billions in revenue annually. Additionally, the company has received numerous accolades for its exemplary corporate social responsibility efforts and commitment to sustainability. With a strong focus on innovation and customer satisfaction, Henry Schein Inc continues to make strides in improving healthcare outcomes and shaping the future of the industry.
Henry Schein Inc is primarily present in multiple countries and regions worldwide. Some of the major markets where the company operates include the United States, Canada, Europe, Australia, New Zealand, and parts of Asia. With its global presence, Henry Schein Inc serves various healthcare professionals and institutions, offering a wide range of products and services in the dental, medical, and animal health sectors. With a strong focus on delivering comprehensive solutions, Henry Schein Inc has established itself as a trusted provider in the healthcare industry across these countries and regions.
Henry Schein Inc is a leading healthcare company that values integrity, innovation, and service excellence. The company's corporate philosophy revolves around enabling healthcare professionals to deliver quality care to patients through enhanced practice management, advanced technology, and superior distribution capabilities. With a focus on building trust and fostering strong relationships, Henry Schein Inc aims to empower healthcare providers by providing them with the tools and resources they need to succeed. By upholding high ethical standards and striving for continuous improvement, Henry Schein Inc is committed to making a positive impact in the healthcare industry.
Analyytikot asettavat tällä hetkellä Henry Schein-osakkeelle keskimääräisen tavoitehinnan 90,80 USD (mediaani: 94,50 USD), mikä merkitsee +6,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 25 analyytikkoarvioon.
25 analyytikkoa arvioi tällä hetkellä Henry Schein-osaketta: 15 suosittaa ostoa, 9 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat Henry Schein-yhtiöltä 13,87 Mrd. USD liikevaihtoa ja 5,23 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Henry Schein-osake noteerataan hintaan 76,53 EUR (85,56 USD).
Henry Schein-osake (HSIC) on listattuna 10 pörssissä, muun muassa: NASDAQ (HSIC), London (0L3C.L), SIX (Zürich) (HSIC.SW), XETRA (HS2.DE), Frankfurt (HS2.F), München (HS2.MU), Düsseldorf (HS2.DU), Hamburg (HS2.HM).
Henry Schein, Inc. is a global provider of health solutions and services for clinic and dental partners. The company has been in operation for over 87 years and is headquartered in Melville, New York. Henry Schein's business model focuses on four main segments: dental products, medical products, veterinary products, and practice management and consulting services. Each segment offers a variety of products and services tailored to the needs of doctors, dentists, and veterinarians. In the dental field, Henry Schein offers a comprehensive range of products such as instruments, equipment, dental materials and accessories, intraoral cameras, X-ray machines and films, and digital impression systems. The company also works closely with dentists by providing training and continuing education programs that enhance practice management skills and help expand patient base. In the medical field, Henry Schein offers a wide range of products including medications, medical instruments, practice supplies, laboratory chemicals, and diagnostics. The company also provides a variety of services such as support in setting up practice management systems, the e-clinic program to support telemedicine and digitization of medical records. Additionally, they also have a veterinary division that provides products and services for veterinarians. This includes animal medications, diagnostics, and surgical instruments. The company also offers veterinary management software to assist veterinarians in managing their practices and patients. Finally, the company offers practice management and consulting services aimed at increasing profitability and efficiency for medical, dental, and veterinary practices. They provide the solution for practice software for billing, appointment scheduling, and integration of patient data as well as training for staff. Henry Schein places strong emphasis on customer retention and support to promote company growth through a range of marketing and sales programs. This includes product offerings, in-depth training for product users, and effective consultations for practice and business strategy. The company is also expanding its presence on social media to reach new customers and engage existing ones. Overall, Henry Schein focuses on innovative and effective solutions to meet the needs of its customers in the healthcare industry. The company strives to offer a diverse and comprehensive range of products and services, aiming to provide customers with compactness and efficiency in their daily work.
odotettu liikevaihto Henry Schein on 13,87 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Henry Schein on 618,73 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Henry Schein:n hinta-voitto-suhde (P/E) on tällä hetkellä 16,36. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Henry Schein-osakkeen arvostusta.
Henry Schein:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,73. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Henry Schein-osakkeen arvostuskennuslukuna.
Henry Schein:n Eulpool-laatuscore on 4/10.
Henry Schein:n ISIN on US8064071025. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Henry Schein:n WKN on 897961. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Henry Schein:n ticker on HSIC. Tämä pörssinoteeraus käytetään Henry Schein-osakkeiden kauppaan pörssissä.
Henry Schein osake
Henry Schein vertaisryhmä
Henry Schein Ticker
Henry Schein FIGI
Kaikki tunnusluvut ja syvällinen analyysi Henry Schein:sta
Meidän osakeanalyysimme Henry Schein-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Henry Schein:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: